When does DocMorris (DOCM.SW) report earnings?

DocMorris AG is scheduled to report after the market close on 19 Mar 2026; investors should monitor EPS, revenue mix and guidance for near-term outlook of DOCM.SW stock.

What are the main valuation figures for DOCM.SW stock?

At close on 18 Mar 2026 DOCM.SW stock was CHF 4.12 with a market cap of CHF 208,393,554.00, price-to-sales of 0.20 and price-to-book of 0.26, reflecting deep valuation discounts.

What price targets does Meyka AI show for DOCM.SW stock?

Meyka AI's forecast model projects a near-term target of CHF 5.56 and a 12‑month target of CHF 6.18 for DOCM.SW stock; these are model outputs and not guarantees.

What are the top risks for DOCM.SW stock after earnings?

Key risks include continued negative EPS, weak free cash flow, and poor guidance. Sector peers trade at stronger multiples, so missed recovery targets could pressure DOCM.SW stock further.

CH Stocks

CHF 4.12 close: DocMorris AG (DOCM.SW, SIX) ahead of earnings 18 Mar 2026: key cues

ByDanny Kontos March 19, 2026March 19, 2026

DOCM.SW stock closed at CHF 4.12 on 18 Mar 2026 as DocMorris AG (DOCM.SW) heads into an earnings release tomorrow. Traders will watch revenue mix, margins and cash flow after a year-to-date slide of -28.41%. Volume rose to 333,914 shares versus an average of 288,401, signalling investor attention ahead of results. Key data points to track in the earnings report include EPS of -4.58, current guidance commentary, and any updates on the company’s Swiss and international pharmacy operations. For company details see the DocMorris investor site source and SIX exchange information source.